A detailed history of Ever Source Wealth Advisors, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 3 shares of TGTX stock, worth $54. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Holding current value
$54
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 11, 2024

BUY
$13.02 - $21.3 $39 - $63
3 New
3 $0
Q2 2022

Aug 01, 2022

SELL
$3.74 - $10.66 $897 - $2,558
-240 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$15.2 - $35.51 $3,648 - $8,522
240 New
240 $5,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $2.66B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.